rebastinib
Showing 1 - 3 of 3
Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,
Terminated
- Breast Cancer
- +4 more
- Rebastinib
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Mar 23, 2022
Locally Advanced or Metastatic Solid Tumor Trial in United States (rebastinib, Carboplatin)
Active, not recruiting
- Locally Advanced or Metastatic Solid Tumor
- rebastinib
- Carboplatin
-
San Francisco, California
- +8 more
Aug 10, 2021
Locally Advanced or Metastatic Solid Tumor Trial in United States (rebastinib, Paclitaxel)
Active, not recruiting
- Locally Advanced or Metastatic Solid Tumor
- rebastinib
- Paclitaxel
-
Birmingham, Alabama
- +13 more
Sep 29, 2021